PerkinElmer Inks Deal to Buy Signature Genomic Laboratories

The acquisition of Signature's diagnostic cytogenetic tests for genetic diseases will enhance PerkinElmer's molecular diagnostic testing portfolio.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories